Share

ARMYDA SWITCH 2

ARMYDA SWITCH 2 - Prasugrel versus ticagrelor versus clopidogrel in ACS patients

Project Objectives

A single-center, randomized study comparing three strategies of antiplatelet therapy (ticagrelor, prasugrel and clopidogrel) in patients with acute coronary syndrome.

Start/End Date

December 2012 - ongoing

Principal Investigator

  • Dr. Giuseppe Patti - Local Principal Investigator
  • Prof. Germano Di Sciascio

Host Institution

Campus Bio-Medico University of Rome

magnifiercrossmenuchevron-downchevron-leftchevron-right